跳至主要内容
临床试验/NCT06930599
NCT06930599尚未招募不适用

Comparison of Pulmonary Vein Isolation With and Without Transitional Zone Modification in Atrial Fibrillation Patients Without Low-Voltage Areas

The First Affiliated Hospital with Nanjing Medical University0 个研究点目标入组 162 人开始时间: 2025年4月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
162
主要终点
Freedom From AF and/or ATs With or Without Antiarrhythmic Drugs (AADs)

研究概览

简要总结

This study investigates two treatments for atrial fibrillation (AF) patients without low-voltage-areas (LVAs). It aims to determine whether adding transition zone modification (TZM) to the pulmonary vein isolation (PVI) improves long-term outcomes compared to PVI alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

Follow-up physicians are blinded to treatment allocation

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Aged 18 to 80 years AF referring for ablation No prior history of AF Absence of low-voltage areas during substrate mapping Presence of transition zone during substrate mapping Sign informed consent

排除标准

  • •Presence of left atrial thrombus Acute coronary syndrome, cardiac surgery, angioplasty, or cerebrovascular accident within three months prior to enrollment Previous cardiac transplantation, complex congenital heart disease, rheumatic heart disease Untreated hypothyroidism or hyperthyroidism Dialysis-dependent terminal renal failure Life expectancy <12 months due to non-cardiovascular causes. Any conditions that, in the opinion of the investigator, may render the patient unable to complete the study Female under pregnancy or breast-feeding Involved in other studies

研究组 & 干预措施

Active Comparator: PVI-alone arm

Active Comparator

干预措施: Pulmonary vein isolation alone (Procedure)

Experimental: PVI+TZM arm

Experimental

干预措施: Pulmonary vein isolation plus transition zone modification (Procedure)

结局指标

主要结局

Freedom From AF and/or ATs With or Without Antiarrhythmic Drugs (AADs)

时间窗: at least 12 months follow up

Freedom from AF and/or ATs with or without antiarrhythmic drugs (AADs) at 12months after a single-ablation procedure. AF and/or AT occurring in the first 3 months after the ablation (blanking period) was censored. Each episode lasts \> 30 seconds.

次要结局

  • Incidence of Peri-procedural Complications(1 week after patient enrollment)
  • Total procedure time(1 week after patient enrollment)
  • Total fluoroscopic time(1 week after patient enrollment)
  • Total RF delivery time(1 week after patient enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Minglong Chen

Dr.

The First Affiliated Hospital with Nanjing Medical University

相似试验